Abcellera Biologics Inc Strategic Asset Allocation Index
Abcellera Biologics Inc strategic asset allocation index. Abcellera Biologics Inc (ABCL) has a Strategic Asset Allocation Index of 7.3% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $65.23 Million) total $65.23 Million, measured against net assets of $896.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check ABCL goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Abcellera Biologics Inc (2018–2025)
Strategic asset allocation index of Abcellera Biologics Inc from 2018 to 2025. This chart shows how Abcellera Biologics Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the index stands at 7.3%, representing strategic assets of $65.23 Million against net assets of $896.02 Million USD.
Abcellera Biologics Inc Strategic Asset Allocation Index by Year (2018–2025)
Abcellera Biologics Inc strategic asset allocation index by year from 2018 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Abcellera Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Abcellera Biologics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.5% | $62.58 Million | $- | $62.58 Million | $966.90 Million | ▼ -1.3 pp |
| 2024 | 7.8% | $82.30 Million | $- | $82.30 Million | $1.06 Billion | ▲ +2.1 pp |
| 2023 | 5.7% | $65.94 Million | $- | $65.94 Million | $1.15 Billion | ▼ -17.8 pp |
| 2022 | 23.5% | $289.78 Million | $217.25 Million | $72.52 Million | $1.23 Billion | ▲ +7.7 pp |
| 2021 | 15.8% | $161.93 Million | $111.62 Million | $50.31 Million | $1.03 Billion | ▲ +11.3 pp |
| 2020 | 4.5% | $37.17 Million | $17.92 Million | $19.25 Million | $830.51 Million | ▼ -78.2 pp |
| 2019 | 82.7% | $8.48 Million | $8.48 Million | $- | $10.25 Million | ▲ +28.2 pp |
| 2018 | 54.5% | $6.33 Million | $6.33 Million | $- | $11.61 Million | — |